Financials
- Market Capitalization 21.65 M
- Employee 18
- Founded 2020
- CEO N/A
- Website www.tevogen.com
- Headquarter Delaware, United States
- FIGI BBG013395405
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.05
売上高対価格比率
-280.95
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4592 | ALGS Aligos Therapeutics, Inc. - Common stock | 6.33 USD | -0.47% | +7.29% | +19.43% | -35.34% | 21.93 M USD | ||
| 4595 | VYNE VYNE Therapeutics Inc. - Common Stock | 0.71 USD | +7.58% | +5.97% | +9.23% | -46.21% | 23.68 M USD | ||
| 4599 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.69 USD | +2.28% | +0.37% | +16.96% | -14.33% | 21.50 M USD | ||
| 4602 | SKYE Skye Bioscience, Inc. - Common Stock | 0.61 USD | -7.58% | -15.28% | -22.78% | -23.75% | 21.44 M USD |